|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Receivables due from related parties | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash (Note 3) | ||||||||||||||||||||
| Receivables, net of allowance for credit losses of $32,726 and $22,648, respectively (Note 2) | ||||||||||||||||||||
| Receivables due from related parties (Note 9) | ||||||||||||||||||||
| Inventory (Note 5) | ||||||||||||||||||||
| Forward contracts for the issuance of convertible preferred stock | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-term assets: | ||||||||||||||||||||
| Goodwill (Note 7) | ||||||||||||||||||||
| Brand name (Note 7) | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Property, plant and equipment, net (Note 6) | ||||||||||||||||||||
| Right-of-use assets (Note 6) | ||||||||||||||||||||
| Equity method investments (Note 9) | ||||||||||||||||||||
| Investment in GNC Canada (Note 3) | ||||||||||||||||||||
| Deferred tax assets (Note 15) | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Debtor-in-possession financing (Note 3) | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Revolving credit facility (Note 5) | ||||||||||||||||||||
| Accounts payable due to related parties | ||||||||||||||||||||
| Accounts payable due to related parties (Note 9) | ||||||||||||||||||||
| Current portion of long-term debt (Note 8) | ||||||||||||||||||||
| Current lease liabilities | ||||||||||||||||||||
| Deferred revenue and other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Long-term debt (Note 8) | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities not subject to compromise | ||||||||||||||||||||
| Liabilities subject to compromise | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Mezzanine equity: | ||||||||||||||||||||
| Convertible preferred stock (Note 12) | ||||||||||||||||||||
| Stockholders’ deficit: | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders’ deficit | ||||||||||||||||||||
Loading...
